Describe how Cancer is Classified
This study guide is intended to help you organize your thoughts; it is not intended to be your only study tool. Utilize the PowerPoints, course content, textbooks, and ATI resources to help you prepare for Exam 1.
Key terms:
Normal Cells | Benign tumor cells | Cancer cells | |
Morphology | |||
Nuclear to cytoplasmic ratio | |||
Function | |||
Adherence | |||
Migratory?? | |||
Growth | |||
Cellular regulation | |||
Describe how Cancer is Classified
Grading: classifies cellular aspects of the cancer
Ploidy: description of cancer cells by chromosome number and appearance
Staging: determines the exact location of cancer and whether metastasis has occurred
Describe the external factors that influence cancer development
Chemical carcinogenesis: can occur from exposures to many known chemicals, drugs, and other produces used in everyday life.
Physical carcinogenesis: from physical agents or events also cause cancer by DNA damage- radiation and chronic irritation
Viral carcinogenesis: occurs when viruses infect body calls and break DNA strands. Viruses insert their own genetic material into human DNA
Oncoviruses- viruses that cause cancer
Describe the personal factors that influence cancer development
Immunity: protects the body from foreign invaders and non-self cells
Age: advancing age is single most important risk factor for cancer – as adult ages immunity decreases and external exposures to carcinogens accumulate
Genetic risk: occurs only in a small percent of population; genetic redisposition are at very high risk for cancer development
Staging of Cancer: Describe TNM Classification-
Describe the difference between primary and secondary cancer prevention:
Describe | Examples | |
Primary | ||
Secondary |
Describe the impact cancer has on physical function
Immunity and clotting:
GI function:
Peripheral nerve function
Motor and sensory deficits:
Respiratory function:
Cardiac function:
Pain and quality of life:
Cancer Management
Surgery
Type of Surgery | Description | Example |
Prophylactic | ||
Diagnostic | ||
Curative | ||
Debulking | ||
Palliative | ||
Reconstructive |
Radiation Therapy
High energy radiation that kills cancer cells by altering DNA and changing cellular regulation. Localized treatment.
What is the difference between radiation exposure and dose?
Exposure:
Dose:
Delivery Methods:
Describe | Nursing Considerations | |
External | ||
Internal |
Side effects and nursing management
Review table 20.2 (page 381). Describe nursing interventions and patient education for clients receiving radiation treatment.
Chemotherapy: DNA and cellular regulation altered by chemicals. Systemic effect.
Administration routes:
Nursing considerations for administration of chemo drugs:
Bone Marrow Suppression | Describe | Patient risk related to side effect | Nursing care and considerations |
Decreased RBC | |||
Decreased WBC | |||
Decreased Platelets | |||
Other Side Effects | |||
Chemo induced n/v | |||
Mucositis | |||
Alopecia | |||
Impaired cognitive function | |||
Peripheral neuropathy |
Briefly describe the different types of Chemotherapy
Immunotherapy:
Monoclonal antibody:
Targeted:
Endocrine therapy:
Colony-stimulating therapy:
Oncologic Emergencies:
Emergency: | Describe (what/where/who) | Signs & symptoms | Treatment/Nursing care and considerations |
Sepsis and DIC | |||
SIADH | |||
Spinal Cord Compression | |||
Hypercalcemia | |||
Superior Vena Cava Syndrome | |||
Tumor Lysis Syndrome |
Fluid and Electrolyte Balance
Define/describe the following:
Solvent:
Solute:
Electrolyte:
Fluid Distribution:
Intracellular
Extracellular
Filtration
Diffusion
Osmosis
Osmolarity
Hormonal Regulation of Fluid Balance | ||
Hormone | Secreted by (gland/organ) | Action |
Aldosterone | ||
ADH | ||
NP |
Renin-Angiotensin-Aldosterone System:
Trigger event:
**Kidneys react to trigger event
Angiotensin II action:
Aldosterone:
ACE (Angiotensin Converting Enzyme) action:
Fluid Imbalance
Type | Cause/Risk factors | Assessment/ Signs and Symptoms | Nursing Considerations/Actions /Pt education |
Fluid volume deficit | |||
Fluid volume excess |
Electrolyte Imbalance
Sodium) (136-145 mEq/L)
Hyponatremia | Hypernatremia | |
Patho | ||
Causes/Risks | ||
Assessment (S/S) CardiovascularNeuromuscularIntestinalLab data | ||
Interventions |
Potassium (3.5-5.0 mEq/L)
Hypokalemia | Hyperkalemia | |
Patho | ||
Causes | ||
Assessment (S/S) CardiovascularNeuromuscularIntestinalLab data | ||
Interventions |
Calcium (9.0-10.5 mg/dL)
Hypocalcemia | Hypercalcemia | |
Patho | ||
Causes | ||
Assessment (S/S) CardiovascularNeuromuscularIntestinalLab data | ||
Interventions |
Magnesium (1.8-2.6 mEq/L)
Hypomagnesemia | Hypermagnesemia | |
Patho | ||
Causes | ||
Assessment (S/S) CardiovascularNeuromuscularIntestinalLab data | ||
Interventions |